Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Triple Body)
TypeName: Business Offer
Category:
Country: United States
Summary: Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD19 antibody are both extended with the scFv fragment from an anti-CD47 antibody. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cd19%2520%2526%2520cd47.htm
Description: Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD19 antibody are both extended with the scFv fragment from an anti-CD47 antibody. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.https://www.creative-biolabs.com/bsab/symbolsearch-cd19%2520%2526%2520cd47.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
